Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Gengos Andrew
Over the trailing 90 days, Gengos Andrew (Other at Terns Pharmaceuticals, Inc.) sold $5.8M of stock across 3 companies, per 6 SEC Form 4 transactions.
- Role
- Other
- Window
- Trailing 90 days · 6 transactions · CIK 1563623
- Net activity
- −$5.8M ($0 bought · $5.8M sold)
By Company (Trailing 90 Days)
Transactions (6)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-16 | IMRX | Buy | 650.0K | $0 | Grant, award or other acquisition |
| 2026-06-04 | TTRX | Buy | 95.0K | $0 | Grant, award or other acquisition |
| 2026-05-05 | TERN | Sell | 68.8K | $3.6M | Disposition to the issuer of issuer equity securities |
| 2026-05-05 | TERN | Sell | 750.0K | $0 | Disposition to the issuer of issuer equity securities |
| 2026-05-05 | TERN | Sell | 137.5K | $0 | Disposition to the issuer of issuer equity securities |
| 2026-05-05 | TERN | Sell | 40.5K | $2.1M | Disposition pursuant to a tender of shares |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Gengos's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.